| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2871033 | The Annals of Thoracic Surgery | 2016 | 6 Pages |
Abstract
Low-dose and early administration of rFVIIa (median total dose 12 mcg/kg) for cardiac surgical bleeding shows potential in achieving hemostasis without increased risk of thromboembolism or acute kidney injury.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jason MS, Brooke MS, Jianghua PhD, Katy RN, BSN, Lucy PharmD, Randy McMillen, Brigid MD,